Moreover, myricetin effectively suppressed the in vivo progression of PCa by disrupting the interaction of the protooncogene protein proviral integration site for Moloney murine leukemia virus-1 (PIM1) with C-X-C chemokine receptor type 4 (CXCR4) [544]. The gene discussed is PIM1; the disease is posterior cortical atrophy.